JCB logo
R&D Systems
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents
Published online 25 July 2005. doi:10.1083/jcb.200503088
The Rockefeller University Press, 0021-9525 $8.00
JCB, Volume 170, Number 3, 455-464
This Article
Right arrow Full Text
Right arrow PDF (Full Text)
Right arrow Supplemental Material Index
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Luo, J.
Right arrow Articles by Cantley, L. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Luo, J.
Right arrow Articles by Cantley, L. C.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Article

 The p85 regulatory subunit of phosphoinositide 3-kinase down-regulates IRS-1 signaling via the formation of a sequestration complex

Ji Luo1,2, Seth J. Field1,2,3, Jennifer Y. Lee1,2, Jeffrey A. Engelman1,2,4, and Lewis C. Cantley1,2

1 Department of Systems Biology, Harvard Medical School
2 Division of Signal Transduction, Beth Israel Deaconess Medical Center, Boston, MA 02115
3 Division of Endocrinology, Massachusetts General Hospital, Boston, MA 02114
4 Department of Hematology/Oncology, Massachusetts General Hospital, Boston, MA 02114

Correspondence to Lewis C. Cantley: lewis_cantley{at}hms.harvard.edu

Phosphoinositide (PI) 3-kinase is required for most insulin and insulin-like growth factor (IGF) 1–dependent cellular responses. The p85 regulatory subunit of PI 3-kinase is required to mediate the insulin-dependent recruitment of PI 3-kinase to the plasma membrane, yet mice with reduced p85 expression have increased insulin sensitivity. To further understand the role of p85, we examined IGF-1–dependent translocation of p85{alpha} by using a green fluorescence protein (GFP)–tagged p85{alpha} (EGFP–p85{alpha}). In response to IGF-1, but not to PDGF signaling, EGFP–p85{alpha} translocates to discrete foci in the cell. These foci contain the insulin receptor substrate (IRS) 1 adaptor molecule, and their formation requires the binding of p85 to IRS-1. Surprisingly, monomeric p85 is preferentially localized to these foci compared with the p85–p110 dimer, and these foci are not sites of phosphatidylinositol-3,4,5-trisphosphate production. Ultrastructural analysis reveals that p85–IRS-1 foci are cytosolic protein complexes devoid of membrane. These results suggest a mechanism of signal down-regulation of IRS-1 that is mediated by monomeric p85 through the formation of a sequestration complex between p85 and IRS-1.

S.J. Field's present address is Division of Endocrinology, Cellular and Molecular Medicine, University of California, San Diego, La Jolla, CA 92093.

Abbreviations used in this paper: IGF, insulin-like growth factor; IRS, insulin receptor substrate; MEF, mouse embryonic fibroblasts; PH, pleckstrin homology; PI, phosphoinositide; PIP3, phosphatidylinositol-3,4,5-trisphosphate; PI-3,4-P2, phosphatidylinositol-3,4-bisphosphate; SH, Src homology; TIRFM, total internal reflection fluorescence microscopy.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents